Correction: Carnitine palmitoyl transferase 1 A is a novel diagnostic and predictive biomarker for breast cancer
BMC Cancer volume 23, Article number: 40 (2023)
Correction: BMC Cancer 21, 409 (2021)
Following publication of the original article , the authors reported an error in the funding section. The funding number for the National Science Foundation of China was incorrect. The funding statement should read as follows:
This research was funded by National Science Foundation of China (81802652), Research Fund of Hubei Province Health Bureau (WJ2015MB144) and Research Fund of Wuhan Public Health Bureau (WX15A12 and WX18Y11). The funders had no role in the design of the study, data collection, analysis, interpretation of data, or in writing the manuscript.
Tan Z, Zou Y, Zhu M, et al. Carnitine palmitoyl transferase 1A is a novel diagnostic and predictive biomarker for breast cancer. BMC Cancer. 2021;21:409. https://doi.org/10.1186/s12885-021-08134-7.
About this article
Cite this article
Tan, Z., Zou, Y., Zhu, M. et al. Correction: Carnitine palmitoyl transferase 1 A is a novel diagnostic and predictive biomarker for breast cancer. BMC Cancer 23, 40 (2023). https://doi.org/10.1186/s12885-023-10518-w